Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
0(0%)
Results Posted
22%(2 trials)
Terminated
2(18%)

Phase Distribution

Ph phase_4
5
45%
Ph not_applicable
5
45%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 4Post-market surveillance
5(50.0%)
N/ANon-phased studies
5(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(9)
Terminated(2)

Detailed Status

Completed9
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 45 (50.0%)
N/A5 (50.0%)

Trials by Status

terminated218%
completed982%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11